Celgene-CELG implied volatility at 58 prior to FDA approval of Revlimid

December 28, 2005 8:09 AM EST Send to a Friend
Celgene (Nasdaq: CELG) : CELG is trading $59.51 in pre-opening trading; above last nights close of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login